We recently published 8 Stocks That Jim Cramer Recently Talked About. Novartis AG (NYSE:NVS) is one of the stocks Jim Cramer ...

We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Novartis AG stands third among the most undervalued ...

Novartis AG (NYSE:NVS) is one of the 11 best European stocks to invest in. On June 23, the company confirmed it had completed the acquisition of Regulus Therapeutics. Following the acquisition ...

Brokerage firm IIFL has warned that due to this development, Divi's Laboratories' annual Earnings Before Interest, Tax, Depreciation and Amortisation (EBITDA) could see a potential decline of 12% to ...

Incyte and Novartis did not immediately respond to Fierce Pharma’s request for comment. Last year, Jakafi brought in $2.7 billion in sales for Incyte, plus $418 million in royalty revenues.

So far, Novartis has negotiated Zolgensma access for half of the SMA patient population in Europe, including for patients in England, Scotland, France, Germany, Italy, Belgium and other countries ...

Novartis has lost a bid to keep a generic version of its top-selling heart failure drug Entresto off the U.S. market by blocking regulators from approving it, though the generic's launch faces ...

Novartis plans to cut 285 jobs at its U.S. HQ in East Hanover as part of a restructuring plan announced earlier by the Swiss pharma giant.

Novartis has been located in Cambridge since May 2002. It has more than 2,300 workers in Cambridge and more than 1 million square feet of factory space. In October 2010, it announced a $600 ...

Novartis is acquiring Anthos Therapeutics for up to $3.08 billion, adding abelacimab, a late-stage anticoagulant, to its cardiovascular portfolio.